Use of dupilumab in pediatric and young adult patients with primary immunodeficiency and moderate/severe atopic dermatitis

被引：0
|
作者：
Zangari, P. [1 ]
Giancotta, C. [1 ]
Pacillo, L. [1 ]
Finocchi, A. [1 ]
Cancrini, C. [1 ]
Palma, P. [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Rome, Italy
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
100410
引用
收藏
页码：279 / 280
页数：2
相关论文
共 50 条
  • [31] Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients
    Dal Bello, Giacomo
    Maurelli, Martina
    Schena, Donatella
    Girolomoni, Giampiero
    Gisondi, Paolo
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [32] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Chao, J.
    Eckert, L.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Plaum, S.
    Graham, N.
    Pirozzi, G.
    Gadkari, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
  • [33] Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis
    Marcant, P.
    Balaye, P.
    Merhi, R.
    Jendoubi, F.
    Nosbaum, A.
    Raison-Peyron, N.
    Du-Thanh, A.
    Lasek, A.
    Ferrier le Bouedec, M. -C.
    Tetart, F.
    Valois, A.
    Barbarot, S.
    Soria, A.
    Jachiet, M.
    Staumont-Salle, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (06) : E394 - E396
  • [34] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [35] Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis
    Staumont-Salle, Delphine
    Barbarot, Sebastien
    Bouaziz, Jean David
    Chan, Chan
    Clibborn, Claire
    Du-Thanh, Aurelie
    Feeney, Claire
    Lejeune, Alexandre
    Misery, Laurent
    Nosbaum, Audrey
    Seneschal, Julien
    Soria, Angele
    Zhang, Fan
    JEADV CLINICAL PRACTICE, 2023, 2 (03): : 518 - 530
  • [36] Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
    Hamilton, Jennifer D.
    Suarez-Farinas, Mayte
    Dhingra, Nikhil
    Cardinale, Irma
    Li, Xuan
    Kostic, Ana
    Ming, Jeffrey E.
    Radin, Allen R.
    Krueger, James G.
    Graham, Neil
    Yancopoulos, George D.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) : 1293 - 1300
  • [37] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Ferrucci, Silvia
    Casazza, Giovanni
    Zussino, Martina
    Tavecchio, Simona
    Marzano, Angelo V.
    Tedeschi, Micol
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [38] Clinically meaningful responses in moderate-to-severe atopic dermatitis patients treated with Dupilumab
    de Bruin-Weller, M.
    Eckert, L.
    Simpson, E. L.
    Cork, M. J.
    Ardeleanu, M.
    Chen, Z.
    Shumel, B.
    Rossi, A. B.
    Graham, N. M. H.
    Pirozzi, G.
    Gadkari, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116
  • [39] MULTICENTER CANADIAN CASE SERIES OF PEDIATRIC PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS TREATED WITH OFF-LABEL DUPILUMAB
    Martinez-Cabriales, Sylvia A.
    Marcoux, Danielle
    Sibbald, Cathryn
    Liy-Wong, Carmen
    Lansang, Perla
    Cunningham, Natalie
    Spring, Shanna
    Gavigan, Genevieve
    Joseph, Marissa
    Tonkin, Rochelle
    Ramien, Michele
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 54 - 55
  • [40] Dupilumab to treat severe recalcitrant atopic dermatitis in a young child
    Mazzoni, Daniel
    Lobo, Yolanka
    Wheller, Laura
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 16 - 16
12345